학술논문

Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway
Document Type
Report
Source
International Journal of Oncology. June 1, 2016, p2704, 9 p.
Subject
Gene expression -- Health aspects
Phenols -- Health aspects
Multiple myeloma -- Genetic aspects -- Development and progression -- Care and treatment
Molecular targeted therapy -- Methods
Transcription factors -- Properties
Language
English
ISSN
1019-6439
Abstract
Abstract. Multiple myeloma (MM) is still an incurable hematological malignancy with a 5-year survival rate of ~35%, despite the use of various treatment options. The nuclear factor κB (NF-κB) pathway [...]